Medicine & Health

Researchers at WashU Medicine have uncovered why some patients with a rare genetic disorder called primary ciliary dyskinesia have worse lung problems than others with the same disorder.

Researchers at WashU Medicine developed a compound, derived from cannabis, that relieves pain in mice but doesn’t affect the brain, thereby avoiding mind-altering side effects and abuse potential.

An AI for Health Institute team unveils a versatile large language model that enables early and accurate prediction of postoperative complications to help improve patient safety and outcomes. 

Fahd A. Ahmad, MD, and Tyler Fraum, MD, have been selected as the 2025-27 Carol B. and Jerome T. Loeb Teaching Fellows at WashU Medicine. 

Five researchers from Washington University have been named senior members of the National Academy of Inventors.

Researchers at the McKelvey School of Engineering have developed a method that leverages artificial intelligence to ensure accurate heart scans without added radiation or cost.

The Undiagnosed Diseases Network at WashU Medicine plans to increase outreach to medically underserved communities and boost the number of patients seen.

Researchers at WashU have developed bioelectronic scaffolds in a unique way that creates new tissues.

WashU Medicine has launched the Center for Rare, Undiagnosed and Genetic Diseases, which brings together researchers and patient communities to create a collaborative network to drive innovative research and accelerate drug discovery.

Benjamin Garcia, the Raymond H. Wittcoff Distinguished Professor at WashU Medicine, along with colleagues Zongtao (Tom) Lin and Dongwen Lyu, received a four-year $2.4 million grant renewal from the National Heart, Lung and Blood Institute, part of the National Institutes of Health (NIH).